Clinical Communication and Collaboration Market Size, Share, and Trends 2024 to 2034

The global clinical communication and collaboration market size estimated at USD 2.54 billion in 2025 and is anticipated to reach around USD 6.80 billion by 2034, expanding at a CAGR of 11.64% from 2025 to 2034. The North America clinical communication and collaboration market size reached USD 680 million in 2024 and is expanding at a CAGR of 11.70% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : January 2025
  • Report Code : 1368
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Clinical Communication and Collaboration Market 

5.1. COVID-19 Landscape: Clinical Communication and Collaboration Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Clinical Communication and Collaboration Market, By Component

8.1. Clinical Communication and Collaboration Market, by Component Type,

8.1.1. Solution

8.1.1.1. Market Revenue and Forecast

8.1.2. Service

8.1.2.1. Market Revenue and Forecast

Chapter 9. Global Clinical Communication and Collaboration Market, By End Use

9.1. Clinical Communication and Collaboration Market, by End Use,

9.1.1. Hospitals

9.1.1.1. Market Revenue and Forecast

9.1.2. Clinics

9.1.2.1. Market Revenue and Forecast

Chapter 10. Global Clinical Communication and Collaboration Market, By Deployment 

10.1. Clinical Communication and Collaboration Market, by Deployment,

10.1.1. Hosted

10.1.1.1. Market Revenue and Forecast

10.1.2. On-Premise

10.1.2.1. Market Revenue and Forecast

Chapter 11. Global Clinical Communication and Collaboration Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Component

11.1.2. Market Revenue and Forecast, by End Use

11.1.3. Market Revenue and Forecast, by Deployment

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Component

11.1.4.2. Market Revenue and Forecast, by End Use

11.1.4.3. Market Revenue and Forecast, by Deployment

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Component

11.1.5.2. Market Revenue and Forecast, by End Use

11.1.5.3. Market Revenue and Forecast, by Deployment

11.2. Europe

11.2.1. Market Revenue and Forecast, by Component

11.2.2. Market Revenue and Forecast, by End Use

11.2.3. Market Revenue and Forecast, by Deployment

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Component

11.2.4.2. Market Revenue and Forecast, by End Use

11.2.4.3. Market Revenue and Forecast, by Deployment

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Component

11.2.5.2. Market Revenue and Forecast, by End Use

11.2.5.3. Market Revenue and Forecast, by Deployment

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Component

11.2.6.2. Market Revenue and Forecast, by End Use

11.2.6.3. Market Revenue and Forecast, by Deployment

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Component

11.2.7.2. Market Revenue and Forecast, by End Use

11.2.7.3. Market Revenue and Forecast, by Deployment

11.3. APAC

11.3.1. Market Revenue and Forecast, by Component

11.3.2. Market Revenue and Forecast, by End Use

11.3.3. Market Revenue and Forecast, by Deployment

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Component

11.3.4.2. Market Revenue and Forecast, by End Use

11.3.4.3. Market Revenue and Forecast, by Deployment

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Component

11.3.5.2. Market Revenue and Forecast, by End Use

11.3.5.3. Market Revenue and Forecast, by Deployment

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Component

11.3.6.2. Market Revenue and Forecast, by End Use

11.3.6.3. Market Revenue and Forecast, by Deployment

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Component

11.3.7.2. Market Revenue and Forecast, by End Use

11.3.7.3. Market Revenue and Forecast, by Deployment

11.4. MEA

11.4.1. Market Revenue and Forecast, by Component

11.4.2. Market Revenue and Forecast, by End Use

11.4.3. Market Revenue and Forecast, by Deployment

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Component

11.4.4.2. Market Revenue and Forecast, by End Use

11.4.4.3. Market Revenue and Forecast, by Deployment

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Component

11.4.5.2. Market Revenue and Forecast, by End Use

11.4.5.3. Market Revenue and Forecast, by Deployment

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Component

11.4.6.2. Market Revenue and Forecast, by End Use

11.4.6.3. Market Revenue and Forecast, by Deployment

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Component

11.4.7.2. Market Revenue and Forecast, by End Use

11.4.7.3. Market Revenue and Forecast, by Deployment

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Component

11.5.2. Market Revenue and Forecast, by End Use

11.5.3. Market Revenue and Forecast, by Deployment

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Component

11.5.4.2. Market Revenue and Forecast, by End Use

11.5.4.3. Market Revenue and Forecast, by Deployment

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Component

11.5.5.2. Market Revenue and Forecast, by End Use

11.5.5.3. Market Revenue and Forecast, by Deployment

Chapter 12. Company Profiles

12.1. Vocera Communications, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Jive Sotware

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Microsoft Corporation

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Everbridge

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Ascom

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. TigerConnect

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Cisco Systems Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. UDG Healthcare PLC

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Spok Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. NEC Corporation

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

12.11. Intelligent Business Communication

12.11.1. Company Overview

12.11.2. Product Offerings

12.11.3. Financial Performance

12.11.4. Recent Initiatives

12.12. Voalte

12.12.1. Company Overview

12.12.2. Product Offerings

12.12.3. Financial Performance

12.12.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

According to Precedence Research, the global clinical communication and collaboration market size was reached at USD 2.26 billion in 2024 and projected to hit USD 6.80 billion by 2034.

The global clinical communication and collaboration market is growing at a CAGR of 11.64% from 2025 to 2034.

The global clinical communication and collaboration market is primarily driven by the rising need for the effective communication systems in healthcare sector to eliminate the medical errors that occurs due to lack of effective communication.

The major players in the clinical communication and collaboration market are Vocera Communications, Inc., Jive Sotware, Microsoft Corporation, Everbridge, Ascom, TigerConnect, Cisco Systems Inc., UDG Healthcare PLC, Spok Inc., NEC Corporation, Intelligent Business Communication, Voalte.

The North America accounted for over 30% of the market share in 2024 and is predicted to sustain its dominance during the forecast period.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client